A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.

@article{Feltner2003ARD,
  title={A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.},
  author={Douglas E. Feltner and Jerri G Crockatt and Steven J Dubovsky and Cal K Cohn and Ram K. Shrivastava and Steven D Targum and Maria Liu-Dumaw and Cathryn M Carter and Atul C. Pande},
  journal={Journal of clinical psychopharmacology},
  year={2003},
  volume={23 3},
  pages={
          240-9
        }
}
Pregabalin is a novel compound under development for the treatment of several types of anxiety disorders. To obtain an initial evaluation of the efficacy and safety of pregabalin in the treatment of generalized anxiety disorder (GAD), we conducted a double-blind, fixed-dose, parallel-group, placebo and active-controlled multicenter 4-week study that compared 271 patients randomized to receive pregabalin 50 mg tid (N = 70), pregabalin 200 mg tid (N = 66), placebo (N = 67), or lorazepam 2 mg tid… CONTINUE READING
Highly Influential
This paper has highly influenced 12 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Highly Cited
This paper has 153 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
SHOWING 1-10 OF 79 CITATIONS, ESTIMATED 52% COVERAGE

153 Citations

01020'01'04'08'12'16
Citations per Year
Semantic Scholar estimates that this publication has 153 citations based on the available data.

See our FAQ for additional information.

Similar Papers

Loading similar papers…